二次性ミトラル反吐の管理のためのトランスキャテーターのエッジツーエッジ修復 - CRT 2025 ガイドラインを超えた
Dan Haberman1, Michael J Reardon2, Gregg W Stone3
1Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, USA.
まとめ
心不全 (HF) の二次性ミトラル反発 (SMR) は一般的で深刻です. 新しい証拠は,トランスキャテーター・エッジ・トゥ・エッジ (TEER) が,現在のガイドラインを超えてより多くの患者に利益をもたらす可能性があることを示唆しています.
科学分野:
- 心臓病科
- 介入心臓科
- 心不全 の 治療
背景:
- 二次性ミトラル反発 (SMR) は,心不全 (HF) の頻繁な合併症である.
- SMRはガイドライン指向医療療法 (GDMT) と心臓再同期療法にもかかわらず予後を著しく悪化させる.
- 現在のガイドラインでは,トランスキャテーターのエッジツーエッジ修復 (TEER) を重症で耐火性SMRに制限しています.
研究 の 目的:
- SMRのTEER用薬の拡大に関する現在の証拠と専門家の意見を検討する.
- SMR管理に関する知識のギャップと将来の研究方向を特定する.
- SMR治療のガイドラインの改訂を参考にする.
主な方法:
- 2025年の心臓血管研究技術 (CRT) 会議での専門家パネルディスカッション
- 最近のピボタルランダム化対照試験 (RESHAPE- HF2, MATTERHORN, EFFORT) のレビュー
- 様々な臨床シナリオにおける新たな証拠の分析
主要な成果:
- 中程度のSMR,無症状患者,および特定のHFサブセットにおけるTEERに関する未解決の質問があります.
- レジストリおよび観察データは,より広範な集団におけるTEERの手順的安全性と臨床的利益を示唆しています.
- 合意は,特定のSMRサブグループでの専用の試験の必要性を支持しています.
結論:
- 既存のガイドラインは,SMRにおける TEERの進化する役割を完全にカバーしていないかもしれません.
- 中度および無症状のSMRにおけるTEERの有効性を明らかにするために,さらなるランダム化試験が必要である.
- 実際のデータに基づいた,より広範なTEERの検討は,SMR管理のために正当化されています.
関連する概念動画
Mitral Regurgitation III: Medical Management
27
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
27
Mitral Stenosis III: Medical Management
20
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
20
Mitral Regurgitation IV: Nursing Management
80
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
80
Mitral Valve Prolapse II: Assessment and Management
39
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
39
Mitral Regurgitation I: Introduction
53
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
53
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
47
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
47


